Navigation Links
Blue Door Pharma and Global Energy Markets Strike Global Export Agreement for Meningitis Vaccine and Pharmaceuticals
Date:1/11/2013

Rockville, MD (PRWEB) January 11, 2013

Blue Door Pharmacies, LLC (T/A Blue Door Pharma) announces it has executed a five year, exclusive joint partnership with Global Energy Markets, LLC for the sale and global distribution of pharmaceuticals and a low cost tetravalent meningitis vaccine. Operating under the joint partnership name BlueGem Global, the companies are in negotiations with organizations in Algeria, the Dominican Republic, Ghana, Indonesia and Iran.

“Global Energy Markets needed Blue Door Pharma’s expertise, and they needed ours,” said Global Energy Markets President and CEO, Sina Soumekhian, “For years our clients have asked for pharmaceutical access, and with this partnership we can provide it. Plus, we believe the low cost meningitis vaccine we provide will prove to be highly desirable in our target markets.”

Global Energy Markets has a broad network of international contacts and a license issued by the U.S. Department of Treasury, Office of Foreign Assets Control (OFAC), allowing them to export items to countries under US sanction. “It is a strong marriage of skills, expertise and regulatory licensing on both sides of the equation,” said Dr. Sheila Alizadeh, Founder and CEO of Blue Door Pharma.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10310124.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. FDA, States Weigh Pharmacy Regulation in Wake of Meningitis Outbreak
2. ShopPharmacyCounter.com Unveils PhenObestin 37.5 to Offset Obesity Effectively
3. Pharmacy researcher finds most popular weight-loss drug strongly alters other drug therapies
4. Devalued and distrusted: Can the pharmaceutical industry restore its broken image?
5. Women’s Excellence in Bladder Control Partners with University Compounding Pharmacy in Troy, MI to Help Women with Chronic Pelvic Pain Conditions
6. Report finds Big Pharma is doing more for access to medicine in developing countries
7. Treating cocaine dependence: A promising new pharmacotherapy
8. UBC professor wins Canadas top pharmaceutical research award
9. Compounding Pharmacists Oppose Greater U.S. Oversight
10. Owner of Meningitis-Linked Pharmacy Declines to Testify Before Congress
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... MA (PRWEB) , ... July 24, 2017 , ... Every ... an invigorating and educational conference, InstructureCon. Each annual event is coupled with a dynamic ... level with a James Bond theme, Mission: InstructureCon 0017. , To extend their ...
(Date:7/24/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... to expand its solution to help government contractors more quickly and cost-effectively comply with ... address the authentication requirements within NIST SP800-171, but no matter how you address ...
(Date:7/24/2017)... ... July 24, 2017 , ... The Topricin Companies, formerly ... for Topricin’s revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. ... long term skin conditions, including cancer. In the short term, overexposure to ...
(Date:7/24/2017)... ... July 24, 2017 , ... Independence Blue Cross ... on an Innovation Collaboration program, have signed a five-year agreement that will marshal ... the care members and patients receive. The agreement also signifies Jefferson Health officially ...
(Date:7/24/2017)... ... ... CDC study shows that, although people are taking more steps to protect themselves from sunburn, ... one case of sunburn within the past year. It’s common and people have been dealing ... only recently have people become conscientious of the risks that accompany sunburns. , The team ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and EDMONTON, Alberta , ... scientists and the University of Alberta in ... data in Nature,s partner journal, Schizophrenia 1 , ... predict instances of schizophrenia with 74% accuracy. This ... severity of specific symptoms in schizophrenia patients with ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/21/2017)... , July 21, 2017  Endo International plc ... completing a comprehensive review of its manufacturing network, the ... and distribution facilities in Huntsville, Alabama ... take place over the next 12 to 18 months. ... impacted by declining volumes of commoditized products and these ...
Breaking Medicine Technology: